Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
miR-15a and 16-1 are downregulated in CD4(+) T cells of multiple sclerosis relapsing patients.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.
Is multiple sclerosis an autoimmune disease?
Combined EPR and Molecular Modeling Study of PPI Dendrimers Interacting with Copper Ions: Effect of Generation and Maltose Decoration.
T cell vaccination in multiple sclerosis: results of a preliminary study.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability.
Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients.
Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.
A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
Coping strategies and mood profiles in patients with multiple sclerosis.
2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.
Targeting human oligodendrocyte progenitors for myelin repair.
The prospects of minocycline in multiple sclerosis.
Epitope spreading in immune-mediated diseases: implications for immunotherapy.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Psychiatric disorders in neurology.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Towards establishing MS prevalence in Latin America and the Caribbean.
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
[Posture disorders in patients with multiple sclerosis.]
The translational biology of remyelination: Past, present, and future.
Risk of invasive pneumococcal disease in people admitted to hospital with selected immune-mediated diseases: record linkage cohort analyses.
Pages
« first
‹ previous
…
182
183
184
185
186
187
188
189
190
…
next ›
last »